OXiGENE, Inc. Email Format

BiotechnologyCalifornia, United States11-50 Employees

OXiGENE, Inc. is a biotechnology company focused on vascular targeted therapy for orphan oncology indications. It develops two classes of therapies—vascular disrupting agents that target existing tumor blood vessels and anti-angiogenic agents that inhibit new vessel formation—recognizing their distinct but complementary actions. The company aims to combine these modalities to enhance cancer treatment, targeting tumor vasculature to promote tumor cell death and prevent revascularization.

Headquartered in South San Francisco, California, the organization operates with a relatively small team. It emphasizes leveraging its intellectual property and development expertise to advance vascular targeted therapy and to bring new cancer treatments to patients worldwide. By focusing on orphan oncology indications, OXiGENE situates itself within the biotechnology research sector as a specialized effort to address unmet needs in cancer care.

Get verified OXiGENE, Inc. emails free

Company overview Employee directory